Peptidylarginine deiminase type I, type II, type III and type IV are expressed in rat epidermis

被引:26
|
作者
Ishigami, A
Asaga, H
Ohsawa, T
Akiyama, K
Maruyama, N
机构
[1] Tokyo Metropolitan Inst Gerontol, Dept Bioact Regulat, Itabashi Ku, Tokyo 1730015, Japan
[2] Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan
来源
BIOMEDICAL RESEARCH-TOKYO | 2001年 / 22卷 / 01期
关键词
D O I
10.2220/biomedres.22.63
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peptidylarginine deiminases (PADs) are post-translational modification enzymes to convert protein arginine to citrulline residues in a calcium ion-dependent manner. Here, we investigated the tissue specific expression of PAD type T, II, III and IV by using a reverse transcription-polymerase chain reaction (RT-PCR) method. The type I mRNA was detected only in the epidermis and stomach, and type III mRNA was detected only in the epidermis and ovary. On the other hand, the type II and type IV mRNAs were found in a variety of tissues such as the epidermis, lung, spleen, stomach, kidney, ovary and uterus. The epidermis is the only tissue in which all four PAD mRNAs were detected. The present study suggests strongly that PADs play functionally important roles during the terminal differentiation of epidermal keratinocytes.
引用
收藏
页码:63 / 65
页数:3
相关论文
共 50 条
  • [31] Peptidylarginine deiminase type 4, anticitrullinated peptide antibodies, and rheumatoid arthritis
    Yamada, R
    AUTOIMMUNITY REVIEWS, 2005, 4 (04) : 201 - 206
  • [32] BINDING OF DNA TO HUMAN TYPE-I, TYPE-II AND TYPE-IV COLLAGENS
    ROSENBERG, AM
    PROKOPCHUK, PA
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1985, 8 (03): : A211 - A211
  • [33] THE DISTRIBUTION OF TYPE-I, TYPE-III, TYPE-IV AND TYPE-V COLLAGENS IN PENETRANT LESIONS OF THE CENTRAL NERVOUS-SYSTEM OF THE RAT
    MAXWELL, WL
    DUANCE, VC
    LEHTO, M
    ASHURST, DE
    BERRY, M
    HISTOCHEMICAL JOURNAL, 1984, 16 (11): : 1219 - 1229
  • [34] IMMUNOHISTOCHEMICAL DETECTION OF TYPE-I, TYPE-III, AND TYPE-IV COLLAGEN IN ENDOMETRIOSIS IMPLANTS
    STOVALL, DW
    ANNERS, JA
    HALME, J
    FERTILITY AND STERILITY, 1992, 57 (05) : 984 - 989
  • [35] IMMUNOHISTOCHEMICAL LOCALIZATION OF TYPE-I, TYPE-III AND TYPE-IV COLLAGENS IN THE SCLERA AND CHOROID
    KONOMI, H
    SANO, J
    NAGAI, Y
    TANAKA, M
    NAKAYASU, K
    NAKAJIMA, A
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1982, 26 (01) : 94 - 94
  • [36] Immunolocalization of type I or type II activin receptors in the rat brain
    Funaba, M
    Murata, T
    Fujimura, H
    Murata, E
    Abe, M
    Torii, K
    JOURNAL OF NEUROENDOCRINOLOGY, 1997, 9 (02) : 105 - 111
  • [37] The second von Willebrand type A domain of cochlin has high affinity for type I, type II and type IV collagens
    Nagy, Ildiko
    Trexler, Maria
    Patthy, Laszlo
    FEBS LETTERS, 2008, 582 (29) : 4003 - 4007
  • [38] Serum type III, IV collagens and TIMP in patients with type II diabetes mellitus
    Ishimura, E
    Nishizawa, Y
    Shoji, S
    Morii, H
    LIFE SCIENCES, 1996, 58 (16) : 1331 - 1337
  • [39] THE DISTRIBUTION OF TYPE-I, TYPE-III, TYPE-IV AND TYPE-V COLLAGEN IN THE HUMAN ARTERY WALL
    SHEKHONIN, BV
    KONDALENKO, VF
    DOMOGATSKY, SP
    RUDIN, AV
    RUKOSUEV, VS
    KARDIOLOGIYA, 1984, 24 (04) : 95 - &
  • [40] IMMUNOMORPHOLOGICAL STUDY OF FIBRONECTIN AND COLLAGEN, TYPE-I, TYPE-III, TYPE-IV AND TYPE-V IN CARDIOSCLEROSIS
    SHEKHONIN, BV
    IDELSON, GL
    KOTELYANSKY, VE
    CHERNOUSOV, MA
    SOTNIKOV, AV
    RUKOSYEV, VS
    ARKHIV PATOLOGII, 1986, 48 (01) : 24 - 31